medigraphic.com
Academia Mexicana de Neurología, A.C.

2009, Número 2

<< Anterior Siguiente >>

Rev Mex Neuroci 2009; 10 (2)


Distonía cervical

Alegría MA, Rodríguez VM, Zavala RA, López RM

Idioma: Español
Referencias bibliográficas: 21
Paginas: 90-102
Archivo PDF: 128.92 Kb.


FRAGMENTO

El término distonía describe una forma específica de hiperactividad muscular involuntaria. La hiperactividad muscular distónica se define como “sostenida y a menudo produce movimientos repetitivos y distorsiones o posturas anormales” (Ad Hoc Committe of the Dystonia Medical Research Foundation, 1984).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology1991; 41(7): 1088-91.

  2. Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Movement Disorders 1991; 6(2): 119-26.

  3. Simpson DM, Blitzer A, Brashear A, Comella C, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an eviddence-based review) A. Neurology 2008; 70: 1699-706.

  4. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990; 40: 277-80.

  5. Poewe W, Deuschl G, Nebe A, et al. For the German Dystonia Study Group. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. J Neurol Neurosurg Psychiatry 1998; 64: 13-7.

  6. Marchetti A, Magar R, Findley L, Larsen JP, Pirtosek Z, et al. Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study. Mov Disord 2005; 20(8): 937-44.

  7. Jankovic J, Voung KD, Ahsan J. Comparison of efficacy and immunogenicity of original verus current botulinum toxin in cervical dystonia. Neurology 2003; 60: 1186-88.

  8. Jost W, Blümel J, Grafe S. Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMINR) in Focal Dystonia. Drugs 2007; 67(5): 669-83.

  9. Benecke R, Jost WH, Kanovsky P, et al. A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 2005; 64: 1949-51.

  10. Lew MF, Adornato BT. Duane DD, et al. Botulinum toxin type B: a double-blind, placebocontrolled, safety and efficacy study in cervical dystonia. Neurology 1997; 49: 701-7.

  11. Pappert E, Germanson T (The Myobloc/Neurobloc European Cervical Dystonia Study Group) Botulinum toxin type B vs type A in toxinnaïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Mov Disord 2008; 23(4): 510-17.

  12. Aoki KR, Ranoux D, Wissel J. Using translational medicine to understand clinical differences between botulinum toxin formulations. European Journal of Neurology 2006; 13(Suppl. 4): 10-19.

  13. Costa J, Espírito-Santo C, Borges A, Ferreira JJ, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003633. DOI: 10.1002/ 14651858.CD003633.pub2.

  14. Costa J, Espírito-Santo C, Borges A, Ferreira JJ, et al. Botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004315. DOI: 10.1002/ 14651858.CD004315.pub2.

  15. Swope D, Barbano R. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurol Clin 2008; 26(Suppl. 1): 54-65.

  16. Jankovic J. Treatment of Cervical Dystonia With Botulinum Toxin. Movement Disorders 2004: 19(Suppl. 8).

  17. Dressler D. Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 2000; 7: 713-18.

  18. Comella CL, Buchman AS, Tanner CM, et al. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology 1992; 42: 878-82.

  19. Speelman J, Brams JW. Cervical dystonia and botulinum treatment: is electromyographic guidance necessary? Movement Disorders 1995; 10(6): 802.

  20. Cordivari C, Misra VJ. Vincent A, Catania S, et al. Secondary Non responsiveness to Botulinum Toxin A in Cervical Dystonia: The Role of Electromyogram-Guided Injections, Botulinum Toxin A Antibody Assay, and the Extensor Digitorum Brevis Test. Movement Disorders 2006; 21(10): 1737 -41.

  21. Jankovic J, Hallett M. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc.; 1994, p. 211-37.




2020     |     www.medigraphic.com